Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
NPJ Vaccines
|
November 11, 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
Maarten Swart, Harmjan Kuipers, Fin Milder, et al.
Scientific Reports
|
April 22, 2017
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
Neal Van Hoeven, Christopher B Fox, Brian Granger, et al.
Infection and Immunity
|
November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines
Diego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Frontiers in Drug Delivery
|
August 21, 2025
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine
William R Lykins, Jeroen Pollet, Jessica A White, et al.
Human Vaccines & Immunotherapeutics
|
December 1, 2015
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant
Crina Stavaru, Adrian Onu, Emilia Lupulescu, et al.
Plos One
|
September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate
Amy R Noe, Diego Espinosa, Xiangming Li, et al.
Frontiers in Immunology
|
December 31, 2024
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
William R Lykins, Jeroen Pollet, Jessica A White, et al.
Frontiers in Immunology
|
July 12, 2021
Optimizing a Multi-Component Intranasal <i>Entamoeba Histolytica</i> Vaccine Formulation Using a Design of Experiments Strategy
Mayuresh M Abhyankar, Mark T Orr, Robert Kinsey, et al.
Nature Communications
|
June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Science Translational Medicine
|
July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
NPJ Vaccines
|
November 11, 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen
Maarten Swart, Harmjan Kuipers, Fin Milder, et al.
Scientific Reports
|
April 22, 2017
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
Neal Van Hoeven, Christopher B Fox, Brian Granger, et al.
Infection and Immunity
|
November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines
Diego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Frontiers in Drug Delivery
|
August 21, 2025
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine
William R Lykins, Jeroen Pollet, Jessica A White, et al.
Human Vaccines & Immunotherapeutics
|
December 1, 2015
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant
Crina Stavaru, Adrian Onu, Emilia Lupulescu, et al.
Plos One
|
September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate
Amy R Noe, Diego Espinosa, Xiangming Li, et al.
Frontiers in Immunology
|
December 31, 2024
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
William R Lykins, Jeroen Pollet, Jessica A White, et al.
Frontiers in Immunology
|
July 12, 2021
Optimizing a Multi-Component Intranasal <i>Entamoeba Histolytica</i> Vaccine Formulation Using a Design of Experiments Strategy
Mayuresh M Abhyankar, Mark T Orr, Robert Kinsey, et al.
Nature Communications
|
June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.
Science Translational Medicine
|
July 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S Arunachalam, NaYoung Ha, S Moses Dennison, et al.
Page
of 15